Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      Show filters

      23 trials found for Breast cancer, Breast Neoplasm

      All(23)
      Recruiting(19)
      Not yet recruiting(4)
      Recruiting
      NCT04389632
      A Study of SGN-B6A in Advanced Solid Tumors

      Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Ovarian Neoplasms, Cutaneous

      Male or Female
      18+ years
      44study location(s)
      Recruiting
      NCT05226871
      Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies

      Breast Cancer, Head and Neck Cancer

      Male or Female
      18+ years
      32study location(s)
      Recruiting
      NCT04767594
      First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.

      Breast Neoplasms

      Male or Female
      18+ years
      193study location(s)
      Recruiting
      NCT05253911
      Tucatinib in Patients With Locally Advanced or Metastatic HER2-positive Breast Cancer Who Received at Least Two Prior Anti-HER2 Treatment Regimens.

      HER2-positive Breast Cancer

      Male or Female
      18+ years
      2study location(s)
      Recruiting
      NCT05208762
      A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

      Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma, Ovarian Neoplasms, Melanoma, Triple Negative Breast Neoplasms, Gastric Cancer

      Male or Female
      18+ years
      24study location(s)
      Recruiting
      NCT03445637
      Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®

      Breast Neoplasm

      Females
      18+ years
      1study location(s)
      Recruiting
      NCT04654208
      Swedish Ibrance Registries Insights (SIRI)

      Malignant Neoplasm of Breast

      Male or Female
      18 - 99 years
      1study location(s)
      Recruiting
      NCT04606446
      Study of PF-07248144 in Advanced or Metastatic Solid Tumors

      Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer

      Male or Female
      18+ years
      106study location(s)
      Recruiting
      NCT04937660
      Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC

      Metastatic Breast Cancer

      Male or Female
      18 - 90 years
      12study location(s)
      Feb 11, 2025 - Planned start date (Not yet recruiting)
      NCT06760637
      Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

      Breast Cancer

      Male or Female
      18+ years
      6study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(23)
      Recruiting(19)
      Not yet recruiting(4)

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.